Methyl morpholine oxide → HCID 86622962, compound
Reaction equation
C[N+]1([O-])CCOCC1.[Cl:9][C:10]1[CH:15]=[CH:14][C:13]([CH2:16][CH2:17][NH:18][C:19](=[O:21])[CH3:20])=[CH:12][C:11]=1[CH2:22][OH:23]>C(Cl)Cl.[Ru]([O-])(=O)(=O)=O.C([N+](CCC)(CCC)CCC)CC>[Cl:9][C:10]1[CH:15]=[CH:14][C:13]([CH2:16][CH2:17][NH:18][C:19](=[O:21])[CH3:20])=[CH:12][C:11]=1[CH:22]=[O:23]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
NMO (184 mg, 1.32 mmol) was added to a sol. of N-[2-(4-chloro-3-hydroxymethyl-phenyl)-ethyl]-acetamide (100 mg, 0.439 mmol) in CH2Cl2 (9.22 mL). The mixture was stirred for 30 min, and tetrapropylammonium perruthenate (15.5 mg, 0.044 mmol) was added. The mixture was stirred for 1 h at rt, and was filtered over celite. The filtrate was evaporated under reduced pressure. Purification of the crude by FC(CH2Cl2/MeOH 49:1) yielded the title compound (50 mg, 50%). LC-MS: tR=0.75 min; ES+: 267.10.
Workup
- stirringThe mixture was stirred for 1 h at rt
- filtrationwas filtered over celite
- customThe filtrate was evaporated under reduced pressure
- customPurification of the crude by FC(CH2Cl2/MeOH 49:1)
Sources & evidence
- ORD record
- ord-0dabdf7747934215a11dce75df8462b6
- Source dataset
- uspto-grants-2011_06
- Patent number
- US07968720B2
Reaction notes
Loading…